The death of 19-year-old Alex Duong from alveolar rhabdomyosarcoma has drawn public attention to a rare and aggressive cancer that disproportionately affects children and young adults.

A triple-drug regimen combining two immunotherapy agents with radiation before surgery appears to activate immune defenses ...

The MarketWatch News Department was not involved in the creation of this content.-- Raised over $20 million in gross proceeds in 2025 and held $11.9 million in cash and cash equiv ...

First Patient Dosed for lead oncology program: ST-01156, a novel oral RBM39 degrader, initiated Phase 1a clinical trials in January 2026 following IND clearance in both the U.S. and China Financing ...

Sun Pharmaceutical Industries Limited has shared clinical updates on Fibromun and Nidlegy, with key studies failing to meet primary endpoints while further trials and regulatory ...

Michael Bishop, who has died aged 90, shared the 1989 Nobel Prize in Physiology or Medicine with Harold Varmus for proving ...

Inhibrx Biosciences is a high-risk, catalyst-driven biotech, with valuation hinging on the clinical success of ozekibart and ...

This report documents a young female patient with microgranular variant acute promyelocytic leukaemia (APL) harbouring ...

Q4 2025 Earnings Call March 30, 2026 4:30 PM EDTCompany ParticipantsPanna Sharma - President, CEO & DirectorDavid Margrave ...

Comedian, Alex Duong passed away at the age of 42. What's alveolar rhabdomyosarcoma, with which he suffered for a year?

In this analysis, researchers evaluated whether beta blocker use is associated with improved survival in patients with solid tumors.

Investigators compared mortality risk among long-term survivors of high-grade serous ovarian cancer versus the general US population to examine how mortality and recurrence trends have changed with ...